Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrovir in HIV-Associated Dementia and Neuromuscular Diseases
NCT00002044Phase 2Completed
- Sponsor
- GSK
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of zidovudine in AIDS Dementia Complex (HAD) and neuromuscular disease (NMD), sponsored by GSK. Primary endpoint: Efficacy of Retrovir in treating AIDS-related dementia and neuromuscular complications. Status: completed.
02
Drugs
zidovudine
03
Conditions
AIDS Dementia Complex (HAD)neuromuscular disease (NMD)
Beyond the preview
Go deeper on NCT00002044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002044.